-
1
-
-
0030734901
-
Relationship between binding affinity and functional activity of nociceptin/orphanin FQ
-
Adapa ID, Toll L (1997). Relationship between binding affinity and functional activity of nociceptin/orphanin FQ. Neuropeptides 31: 403-408.
-
(1997)
Neuropeptides
, vol.31
, pp. 403-408
-
-
Adapa, I.D.1
Toll, L.2
-
3
-
-
0033821875
-
Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor
-
Bloms-Funke P, Gillen C, Schuettler AJ, Wnendt S (2000). Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor. Peptides 21: 1141-1146.
-
(2000)
Peptides
, vol.21
, pp. 1141-1146
-
-
Bloms-Funke, P.1
Gillen, C.2
Schuettler, A.J.3
Wnendt, S.4
-
4
-
-
0028284167
-
Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type
-
Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M et al. (1994). Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett 347: 284-288.
-
(1994)
FEBS Lett
, vol.347
, pp. 284-288
-
-
Bunzow, J.R.1
Saez, C.2
Mortrud, M.3
Bouvier, C.4
Williams, J.T.5
Low, M.6
-
5
-
-
0033821777
-
Species differences in the efficacy of compounds at the nociceptin receptor (ORL1)
-
Burnside JL, Rodriguez L, Toll L (2000). Species differences in the efficacy of compounds at the nociceptin receptor (ORL1). Peptides 21: 1147-1154.
-
(2000)
Peptides
, vol.21
, pp. 1147-1154
-
-
Burnside, J.L.1
Rodriguez, L.2
Toll, L.3
-
6
-
-
0031577964
-
Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids
-
Butour JL, Moisand C, Mazarguil H, Mollereau C, Meunier JC (1997). Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids. Eur J Pharmacol 321: 97-103.
-
(1997)
Eur J Pharmacol
, vol.321
, pp. 97-103
-
-
Butour, J.L.1
Moisand, C.2
Mazarguil, H.3
Mollereau, C.4
Meunier, J.C.5
-
8
-
-
0034101842
-
Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist
-
Calo G, Guerrini R, Bigoni R, Rizzi A, Marzola G, Okawa H et al. (2000). Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br J Pharmacol 129: 1183-1193.
-
(2000)
Br J Pharmacol
, vol.129
, pp. 1183-1193
-
-
Calo, G.1
Guerrini, R.2
Bigoni, R.3
Rizzi, A.4
Marzola, G.5
Okawa, H.6
-
9
-
-
0030571060
-
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin
-
Calo G, Rizzi A, Bogoni G, Neugebauer V, Salvadori S, Guerrini R et al. (1996). The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur J Pharmacol 311: R3-R5.
-
(1996)
Eur J Pharmacol
, vol.311
-
-
Calo, G.1
Rizzi, A.2
Bogoni, G.3
Neugebauer, V.4
Salvadori, S.5
Guerrini, R.6
-
10
-
-
0036015187
-
2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor
-
2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br J Pharmacol 136: 303-311.
-
(2002)
Br J Pharmacol
, vol.136
, pp. 303-311
-
-
Calo, G.1
Rizzi, A.2
Rizzi, D.3
Bigoni, R.4
Guerrini, R.5
Marzola, G.6
-
12
-
-
14344252989
-
2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor
-
2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor. J Pharmacol Exp Ther 312: 1114-1123.
-
(2005)
J Pharmacol Exp Ther
, vol.312
, pp. 1114-1123
-
-
Carra, G.1
Rizzi, A.2
Guerrini, R.3
Barnes, T.A.4
McDonald, J.5
Hebbes, C.P.6
-
13
-
-
0015861774
-
Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction
-
Cheng Y-C, Prusoff WH (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
-
(1973)
Biochem Pharmacol
, vol.22
, pp. 3099-3108
-
-
Cheng, Y.-C.1
Prusoff, W.H.2
-
14
-
-
33745258231
-
Endogenous orphanin FQ/nociceptin is involved in the development of morphine tolerance
-
Chung S, Pohl S, Zeng J, Civelli O, Reinscheid RK (2006). Endogenous orphanin FQ/nociceptin is involved in the development of morphine tolerance. J Pharmacol Exp Ther 318: 262-267.
-
(2006)
J Pharmacol Exp Ther
, vol.318
, pp. 262-267
-
-
Chung, S.1
Pohl, S.2
Zeng, J.3
Civelli, O.4
Reinscheid, R.K.5
-
15
-
-
0034666649
-
Effect of nociceptin/orphanin FQ on the rewarding properties of morphine
-
Ciccocioppo R, Angeletti S, Sanna PP, Weiss F, Massi M (2000). Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur J Pharmacol 404: 153-159.
-
(2000)
Eur J Pharmacol
, vol.404
, pp. 153-159
-
-
Ciccocioppo, R.1
Angeletti, S.2
Sanna, P.P.3
Weiss, F.4
Massi, M.5
-
16
-
-
1642267207
-
Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats
-
Ciccocioppo R, Economidou D, Fedeli A, Angeletti S, Weiss F, Heilig M et al. (2004). Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology (Berl) 172: 170-178.
-
(2004)
Psychopharmacology (Berl)
, vol.172
, pp. 170-178
-
-
Ciccocioppo, R.1
Economidou, D.2
Fedeli, A.3
Angeletti, S.4
Weiss, F.5
Heilig, M.6
-
17
-
-
33845188832
-
Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system
-
Ciccocioppo R, Economidou D, Rimondini R, Sommer W, Massi M, Heilig M (2007). Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system. Biol Psychiatry 61: 4-12.
-
(2007)
Biol Psychiatry
, vol.61
, pp. 4-12
-
-
Ciccocioppo, R.1
Economidou, D.2
Rimondini, R.3
Sommer, W.4
Massi, M.5
Heilig, M.6
-
18
-
-
0017756322
-
Agonist and antagonist properties of buprenorphine, a new antinociceptive agent
-
Cowan A, Lewis JW, Macfarlane IR (1977). Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 60: 537-545.
-
(1977)
Br J Pharmacol
, vol.60
, pp. 537-545
-
-
Cowan, A.1
Lewis, J.W.2
Macfarlane, I.R.3
-
19
-
-
0034920548
-
Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: Rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo
-
Dautzenberg FM, Wichmann J, Higelin J, Py-Lang G, Kratzeisen C, Malherbe P et al. (2001). Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo. J Pharmacol Exp Ther 298: 812-819.
-
(2001)
J Pharmacol Exp Ther
, vol.298
, pp. 812-819
-
-
Dautzenberg, F.M.1
Wichmann, J.2
Higelin, J.3
Py-Lang, G.4
Kratzeisen, C.5
Malherbe, P.6
-
21
-
-
0343150924
-
Orphanin FQ: Receptor binding and analog structure activity relationships in rat brain
-
Dooley CT, Houghten RA (1996). Orphanin FQ: receptor binding and analog structure activity relationships in rat brain. Life Sci 59: PL23-PL29.
-
(1996)
Life Sci
, vol.59
-
-
Dooley, C.T.1
Houghten, R.A.2
-
22
-
-
0030831767
-
Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1
-
Dooley CT, Spaeth CG, Berzetei-Gurske IP, Craymer K, Adapa ID, Brandt SR et al. (1997). Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. J Pharmacol Exp Ther 283: 735-741.
-
(1997)
J Pharmacol Exp Ther
, vol.283
, pp. 735-741
-
-
Dooley, C.T.1
Spaeth, C.G.2
Berzetei-Gurske, I.P.3
Craymer, K.4
Adapa, I.D.5
Brandt, S.R.6
-
24
-
-
0038730667
-
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: Pharmacological and genetic evidences from the mouse forced swimming test
-
Gavioli EC, Marzola G, Guerrini R, Bertorelli R, Zucchini S, De Lima TC et al. (2003). Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci 17: 1987-1990.
-
(2003)
Eur J Neurosci
, vol.17
, pp. 1987-1990
-
-
Gavioli, E.C.1
Marzola, G.2
Guerrini, R.3
Bertorelli, R.4
Zucchini, S.5
De Lima, T.C.6
-
25
-
-
0030937860
-
Modulation of enkephalin release by nociceptin (orphanin FQ)
-
Gintzler AR, Adapa ID, Toll L, Medina VM, Wang L (1997). Modulation of enkephalin release by nociceptin (orphanin FQ). Eur J Pharmacol 325: 29-34.
-
(1997)
Eur J Pharmacol
, vol.325
, pp. 29-34
-
-
Gintzler, A.R.1
Adapa, I.D.2
Toll, L.3
Medina, V.M.4
Wang, L.5
-
27
-
-
0031006367
-
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide
-
Guerrini R, Calo G, Rizzi A, Bianchi C, Lazarus LH, Salvadori S et al. (1997). Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem 40: 1789-1793.
-
(1997)
J Med Chem
, vol.40
, pp. 1789-1793
-
-
Guerrini, R.1
Calo, G.2
Rizzi, A.3
Bianchi, C.4
Lazarus, L.H.5
Salvadori, S.6
-
28
-
-
0031974718
-
A new selective antagonist of the nociceptin receptor
-
Guerrini R, Calo G, Rizzi A, Bigoni R, Bianchi C, Salvadori S et al. (1998). A new selective antagonist of the nociceptin receptor. Br J Pharmacol 123: 163-165.
-
(1998)
Br J Pharmacol
, vol.123
, pp. 163-165
-
-
Guerrini, R.1
Calo, G.2
Rizzi, A.3
Bigoni, R.4
Bianchi, C.5
Salvadori, S.6
-
29
-
-
0035028389
-
Comparison of pharmacological activities of buprenorphine and norbuprenorphine: Norbuprenorphine is a potent opioid agonist
-
Huang P, Kehner GB, Cowan A, Liu-Chen LY (2001). Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. J Pharmacol Exp Ther 297: 688-695.
-
(2001)
J Pharmacol Exp Ther
, vol.297
, pp. 688-695
-
-
Huang, P.1
Kehner, G.B.2
Cowan, A.3
Liu-Chen, L.Y.4
-
30
-
-
15644375193
-
3-Alkyl ethers of clocinnamox: Delayed long-term muantagonists with variable mu efficacy
-
Husbands SM, Sadd J, Broadbear JH, Woods JH, Martin J, Traynor JR et al. (1998). 3-Alkyl ethers of clocinnamox: delayed long-term muantagonists with variable mu efficacy. J Med Chem 41: 3493-3498.
-
(1998)
J Med Chem
, vol.41
, pp. 3493-3498
-
-
Husbands, S.M.1
Sadd, J.2
Broadbear, J.H.3
Woods, J.H.4
Martin, J.5
Traynor, J.R.6
-
31
-
-
0037674014
-
Opioid ligands having delayed longterm antagonist activity: Potential pharmacotherapies for opioid abuse
-
Husbands SM, Lewis JW (2003). Opioid ligands having delayed longterm antagonist activity: potential pharmacotherapies for opioid abuse. Mini Rev Med Chem 3: 137-144.
-
(2003)
Mini Rev Med Chem
, vol.3
, pp. 137-144
-
-
Husbands, S.M.1
Lewis, J.W.2
-
32
-
-
0034712756
-
A synthetic agonist at the orphanin FQ/ nociceptin receptor ORL1: Anxiolytic profile in the rat
-
Jenck F, Wichmann J, Dautzenberg FM, Moreau JL, Ouagazzal AM, Martin JR et al. (2000). A synthetic agonist at the orphanin FQ/ nociceptin receptor ORL1: anxiolytic profile in the rat. Proc Natl Acad Sci USA 97: 4938-4943.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 4938-4943
-
-
Jenck, F.1
Wichmann, J.2
Dautzenberg, F.M.3
Moreau, J.L.4
Ouagazzal, A.M.5
Martin, J.R.6
-
33
-
-
0033576679
-
-
Kawamoto H, Ozaki S, Itoh Y, Miyaji M, Arai S, Nakashima H et al. (1999). Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397). J Med Chem 42: 5061-5063.
-
Kawamoto H, Ozaki S, Itoh Y, Miyaji M, Arai S, Nakashima H et al. (1999). Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397). J Med Chem 42: 5061-5063.
-
-
-
-
34
-
-
33846461154
-
SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin- 2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: Analgesic and rewarding properties in mice
-
Khroyan TV, Zaveri NT, Polgar WE, Orduna J, Olsen C, Jiang F et al. (2007). SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin- 2-one], a novel mixed nociceptin/orphanin FQ/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice. J Pharmacol Exp Ther 320: 934-943.
-
(2007)
J Pharmacol Exp Ther
, vol.320
, pp. 934-943
-
-
Khroyan, T.V.1
Zaveri, N.T.2
Polgar, W.E.3
Orduna, J.4
Olsen, C.5
Jiang, F.6
-
35
-
-
33947262606
-
The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking
-
Kuzmin A, Kreek MJ, Bakalkin G, Liljequist S (2007). The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking. Neuropsychopharmacology 32: 902-910.
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 902-910
-
-
Kuzmin, A.1
Kreek, M.J.2
Bakalkin, G.3
Liljequist, S.4
-
36
-
-
33644938251
-
Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes
-
Lester PA, Traynor JR (2006). Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes. Brain Res 1073-1074: 290-296.
-
(2006)
Brain Res
, vol.1073-1074
, pp. 290-296
-
-
Lester, P.A.1
Traynor, J.R.2
-
37
-
-
0345687444
-
Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors
-
Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W et al. (2003). Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci 23: 10331-10337.
-
(2003)
J Neurosci
, vol.23
, pp. 10331-10337
-
-
Lutfy, K.1
Eitan, S.2
Bryant, C.D.3
Yang, Y.C.4
Saliminejad, N.5
Walwyn, W.6
-
38
-
-
0034774632
-
Orphanin FQ/nociceptin attenuates the development of morphine tolerance in rats
-
Lutfy K, Hossain SM, Khaliq I, Maidment NT (2001). Orphanin FQ/nociceptin attenuates the development of morphine tolerance in rats. Br J Pharmacol 134: 529-534.
-
(2001)
Br J Pharmacol
, vol.134
, pp. 529-534
-
-
Lutfy, K.1
Hossain, S.M.2
Khaliq, I.3
Maidment, N.T.4
-
39
-
-
0035666475
-
Morphine tolerance and dependence in the nociceptin receptor knockout mice
-
Mamiya T, Noda Y, Ren X, Nagai T, Takeshima H, Ukai M et al. (2001). Morphine tolerance and dependence in the nociceptin receptor knockout mice. J Neural Transm 108: 1349-1361.
-
(2001)
J Neural Transm
, vol.108
, pp. 1349-1361
-
-
Mamiya, T.1
Noda, Y.2
Ren, X.3
Nagai, T.4
Takeshima, H.5
Ukai, M.6
-
40
-
-
0029166509
-
Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
-
Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P et al. (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377: 532-535.
-
(1995)
Nature
, vol.377
, pp. 532-535
-
-
Meunier, J.C.1
Mollereau, C.2
Toll, L.3
Suaudeau, C.4
Moisand, C.5
Alvinerie, P.6
-
41
-
-
0030598929
-
Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ
-
Mogil JS, Grisel JE, Zhangs G, Belknap JK, Grandy DK (1996). Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci Lett 214: 131-134.
-
(1996)
Neurosci Lett
, vol.214
, pp. 131-134
-
-
Mogil, J.S.1
Grisel, J.E.2
Zhangs, G.3
Belknap, J.K.4
Grandy, D.K.5
-
42
-
-
0028226886
-
ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization
-
Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P et al. (1994). ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341: 33-38.
-
(1994)
FEBS Lett
, vol.341
, pp. 33-38
-
-
Mollereau, C.1
Parmentier, M.2
Mailleux, P.3
Butour, J.L.4
Moisand, C.5
Chalon, P.6
-
43
-
-
0033821652
-
Cellular neurophysiological actions of nociceptin/orphanin FQ
-
Moran TD, Abdulla FA, Smith PA (2000). Cellular neurophysiological actions of nociceptin/orphanin FQ. Peptides 21: 969-976.
-
(2000)
Peptides
, vol.21
, pp. 969-976
-
-
Moran, T.D.1
Abdulla, F.A.2
Smith, P.A.3
-
44
-
-
0033583931
-
Orphanin FQ/nociceptin blocks acquisition of morphine place preference
-
Murphy NP, Lee Y, Maidment NT (1999). Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res 832: 168-170.
-
(1999)
Brain Res
, vol.832
, pp. 168-170
-
-
Murphy, N.P.1
Lee, Y.2
Maidment, N.T.3
-
45
-
-
0344631766
-
Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding
-
Neal Jr CR, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Akil H et al. (1999). Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol 412: 563-605.
-
(1999)
J Comp Neurol
, vol.412
, pp. 563-605
-
-
Neal Jr, C.R.1
Mansour, A.2
Reinscheid, R.3
Nothacker, H.P.4
Civelli, O.5
Akil, H.6
-
46
-
-
0030983770
-
Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor
-
Nishi M, Houtani T, Noda Y, Mamiya T, Sato K, Doi T et al. (1997). Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J 16: 1858-1864.
-
(1997)
EMBO J
, vol.16
, pp. 1858-1864
-
-
Nishi, M.1
Houtani, T.2
Noda, Y.3
Mamiya, T.4
Sato, K.5
Doi, T.6
-
47
-
-
0034683206
-
In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist
-
Ozaki S, Kawamoto H, Itoh Y, Miyaji M, Azuma T, Ichikawa D et al. (2000). In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist. Eur J Pharmacol 402: 45-53.
-
(2000)
Eur J Pharmacol
, vol.402
, pp. 45-53
-
-
Ozaki, S.1
Kawamoto, H.2
Itoh, Y.3
Miyaji, M.4
Azuma, T.5
Ichikawa, D.6
-
48
-
-
0342726574
-
Structure-activity relationship studies on the novel neuropeptide orphanin FQ
-
Reinscheid RK, Ardati A, Monsma Jr FJ, Civelli O (1996). Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem 271: 14163-14168.
-
(1996)
J Biol Chem
, vol.271
, pp. 14163-14168
-
-
Reinscheid, R.K.1
Ardati, A.2
Monsma Jr, F.J.3
Civelli, O.4
-
49
-
-
0028971215
-
Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor
-
Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR et al. (1995). Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270: 792-794.
-
(1995)
Science
, vol.270
, pp. 792-794
-
-
Reinscheid, R.K.1
Nothacker, H.P.2
Bourson, A.3
Ardati, A.4
Henningsen, R.A.5
Bunzow, J.R.6
-
50
-
-
0035002663
-
Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues
-
Rizzi D, Bigoni R, Rizzi A, Jenck F, Wichmann J, Guerrini R et al. (2001). Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues. Naunyn Schmiedebergs Arch Pharmacol 363: 551-555.
-
(2001)
Naunyn Schmiedebergs Arch Pharmacol
, vol.363
, pp. 551-555
-
-
Rizzi, D.1
Bigoni, R.2
Rizzi, A.3
Jenck, F.4
Wichmann, J.5
Guerrini, R.6
-
51
-
-
0036139497
-
Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: In vitro and in vivo studies
-
Rizzi D, Rizzi A, Bigoni R, Camarda V, Marzola G, Guerrini R et al. (2002). Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies. J Pharmacol Exp Ther 300: 57-63.
-
(2002)
J Pharmacol Exp Ther
, vol.300
, pp. 57-63
-
-
Rizzi, D.1
Rizzi, A.2
Bigoni, R.3
Camarda, V.4
Marzola, G.5
Guerrini, R.6
-
52
-
-
0342749308
-
High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor
-
Rover S, Adam G, Cesura AM, Galley G, Jenck F, Monsma Jr FJ et al. (2000). High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor. J Med Chem 43: 1329-1338.
-
(2000)
J Med Chem
, vol.43
, pp. 1329-1338
-
-
Rover, S.1
Adam, G.2
Cesura, A.M.3
Galley, G.4
Jenck, F.5
Monsma Jr, F.J.6
-
53
-
-
23844554269
-
-
Shoblock JR, Wichmann J, Maidment NT (2005). The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference. Neuropharmacology 49: 439-446.
-
Shoblock JR, Wichmann J, Maidment NT (2005). The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference. Neuropharmacology 49: 439-446.
-
-
-
-
54
-
-
0032956076
-
Antinociceptive effects of opioids following acute and chronic administration of butorphanol: Influence of stimulus intensity and relative efficacy at the mu receptor
-
Smith MA, Barrett AC, Picker MJ (1999). Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor. Psychopharmacology (Berl) 143: 261-269.
-
(1999)
Psychopharmacology (Berl)
, vol.143
, pp. 261-269
-
-
Smith, M.A.1
Barrett, A.C.2
Picker, M.J.3
-
55
-
-
0242499509
-
Effect of JTC-801 (nociceptin antagonist) on neuropathic pain in a rat model
-
Suyama H, Kawamoto M, Gaus S, Yuge O (2003). Effect of JTC-801 (nociceptin antagonist) on neuropathic pain in a rat model. Neurosci Lett 351: 133-136.
-
(2003)
Neurosci Lett
, vol.351
, pp. 133-136
-
-
Suyama, H.1
Kawamoto, M.2
Gaus, S.3
Yuge, O.4
-
56
-
-
8044238345
-
Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: Antagonism in brain and potentiation in spinal cord of the rat
-
Tian JH, Xu W, Fang Y, Mogil JS, Grisel JE, Grandy DK et al. (1997). Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br J Pharmacol 120: 676-680.
-
(1997)
Br J Pharmacol
, vol.120
, pp. 676-680
-
-
Tian, J.H.1
Xu, W.2
Fang, Y.3
Mogil, J.S.4
Grisel, J.E.5
Grandy, D.K.6
-
57
-
-
0032012257
-
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications
-
Toll L, Berzetei-Gurske IP, Polgar WE, Brandt SR, Adapa ID, Rodriguez L et al. (1998). Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. NIDA Res Monogr 178: 440-466.
-
(1998)
NIDA Res Monogr
, vol.178
, pp. 440-466
-
-
Toll, L.1
Berzetei-Gurske, I.P.2
Polgar, W.E.3
Brandt, S.R.4
Adapa, I.D.5
Rodriguez, L.6
-
58
-
-
0028986870
-
35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells
-
35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47: 848-854.
-
(1995)
Mol Pharmacol
, vol.47
, pp. 848-854
-
-
Traynor, J.R.1
Nahorski, S.R.2
-
59
-
-
0034667560
-
Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence
-
Ueda H, Inoue M, Takeshima H, Iwasawa Y (2000). Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence. J Neurosci 20: 7640-7647.
-
(2000)
J Neurosci
, vol.20
, pp. 7640-7647
-
-
Ueda, H.1
Inoue, M.2
Takeshima, H.3
Iwasawa, Y.4
-
60
-
-
0028225109
-
cDNA cloning of an orphan opiate receptor gene family member and its splice variant
-
Wang JB, Johnson PS, Imai Y, Persico AM, Ozenberger BA, Eppler CM et al. (1994). cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett 348: 75-79.
-
(1994)
FEBS Lett
, vol.348
, pp. 75-79
-
-
Wang, J.B.1
Johnson, P.S.2
Imai, Y.3
Persico, A.M.4
Ozenberger, B.A.5
Eppler, C.M.6
-
61
-
-
0345552248
-
Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay
-
Wnendt S, Kruger T, Janocha E, Hildebrandt D, Englberger W (1999). Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay. Mol Pharmacol 56: 334-338.
-
(1999)
Mol Pharmacol
, vol.56
, pp. 334-338
-
-
Wnendt, S.1
Kruger, T.2
Janocha, E.3
Hildebrandt, D.4
Englberger, W.5
-
62
-
-
0028991723
-
Methoclocinnamox: A mu partial agonist with pharmacotherapeutic potential for heroin abuse
-
Woods JH, Lewis JW, Winger G, Butelman E, Broadbear J, Zernig G (1995). Methoclocinnamox: a mu partial agonist with pharmacotherapeutic potential for heroin abuse. NIDA Res Monogr 147: 195-219.
-
(1995)
NIDA Res Monogr
, vol.147
, pp. 195-219
-
-
Woods, J.H.1
Lewis, J.W.2
Winger, G.3
Butelman, E.4
Broadbear, J.5
Zernig, G.6
-
63
-
-
0029806549
-
Nociceptin or antinociceptin: Potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat
-
Xu XJ, Hao JX, Wiesenfeld-Hallin Z (1996). Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport 7: 2092-2094.
-
(1996)
NeuroReport
, vol.7
, pp. 2092-2094
-
-
Xu, X.J.1
Hao, J.X.2
Wiesenfeld-Hallin, Z.3
-
64
-
-
0036177296
-
Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801
-
Yamada H, Nakamoto H, Suzuki Y, Ito T, Aisaka K (2002). Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801. Br J Pharmacol 135: 323-332.
-
(2002)
Br J Pharmacol
, vol.135
, pp. 323-332
-
-
Yamada, H.1
Nakamoto, H.2
Suzuki, Y.3
Ito, T.4
Aisaka, K.5
-
65
-
-
1642498186
-
Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1- methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8, 9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)
-
Zaratin PF, Petrone G, Sbacchi M, Garnier M, Fossati C, Petrillo P et al. (2004). Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1- methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8, 9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111). J Pharmacol Exp Ther 308: 454-461.
-
(2004)
J Pharmacol Exp Ther
, vol.308
, pp. 454-461
-
-
Zaratin, P.F.1
Petrone, G.2
Sbacchi, M.3
Garnier, M.4
Fossati, C.5
Petrillo, P.6
-
66
-
-
0037498440
-
Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: Research tools and potential therapeutic agents
-
Zaveri N (2003). Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents. Life Sci 73: 663-678.
-
(2003)
Life Sci
, vol.73
, pp. 663-678
-
-
Zaveri, N.1
-
67
-
-
30544437362
-
Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): Ligand-based analysis of structural factors influencing intrinsic activity at NOP
-
Zaveri N, Jiang F, Olsen C, Polgar W, Toll L (2005). Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): ligand-based analysis of structural factors influencing intrinsic activity at NOP. AAPS J 7: E345-E352.
-
(2005)
AAPS J
, vol.7
-
-
Zaveri, N.1
Jiang, F.2
Olsen, C.3
Polgar, W.4
Toll, L.5
-
68
-
-
0035964719
-
Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors
-
Zaveri N, Polgar WE, Olsen CM, Kelson AB, Grundt P, Lewis JW et al. (2001). Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors. Eur J Pharmacol 428: 29-36.
-
(2001)
Eur J Pharmacol
, vol.428
, pp. 29-36
-
-
Zaveri, N.1
Polgar, W.E.2
Olsen, C.M.3
Kelson, A.B.4
Grundt, P.5
Lewis, J.W.6
-
69
-
-
2542609191
-
A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor
-
Zaveri NT, Jiang F, Olsen CM, Deschamps JR, Parrish D, Polgar W et al. (2004). A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor. J Med Chem 47: 2973-2976.
-
(2004)
J Med Chem
, vol.47
, pp. 2973-2976
-
-
Zaveri, N.T.1
Jiang, F.2
Olsen, C.M.3
Deschamps, J.R.4
Parrish, D.5
Polgar, W.6
|